Different perspectives and viewpoints on the postoperative management of EGFR-mutant lung cancer | Zendy

Masayuki Nakao | Zendy; Junji Ichinose | Zendy; Yosuke Matsuura | Zendy; Sakae Okumura | Zendy; Mingyon Mun | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Different perspectives and viewpoints on the postoperative management of EGFR-mutant lung cancer

Author(s) -

Masayuki Nakao,

Junji Ichinose,

Yosuke Matsuura,

Sakae Okumura,

Mingyon Mun

Publication year - 2020

Publication title -

annals of translational medicine

Language(s) - English

Resource type - Journals

eISSN - 2305-5847

pISSN - 2305-5839

DOI - 10.21037/atm.2020.04.34

Subject(s) - viewpoints , lung cancer , medicine , mutant , cancer research , oncology , biology , gene , genetics , art , visual arts

Department of Thoracic Surgical Oncology, Cancer Institute Hospital, The Japanese Foundation for Cancer Research, Tokyo, Japan Correspondence to: Masayuki Nakao, MD. Cancer Institute Hospital, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan. Email: masayuki.nakao@jfcr.or.jp. Provenance and Peer Review: This article was commissioned by the editorial office, Annals of Translational Medicine. The article did not undergo external peer review. Comment on: Liang W, Cai K, Chen C, et al. Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition). Transl Lung Cancer Res 2019;8:1163-73.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research